Company information not available

Glaukos® Corporation is an ophthalmic medical technology company located in San Clemente, California, that is dedicated to researching and developing micro-technologies to improve glaucoma therapy and has developed the iStent® Trabecular Micro-Bypass Stent. The iStent is intended to reduce IOP in patients and dependence on ocular hypotensive medications in patients with mild-to-moderate open-angle glaucoma. The iStent is CE marked with availability in selected markets in Europe, has a Medical Device License in Canada and is FDA approved in the USA.